National Center for Child Health and Development

Tokyo 157-8535

3 studies enrolling now · 9 studies all time

What they study most

Bronchopulmonary Dysplasia, CPSS (Congenital Portosystemic Shunt), Childhood Idiopathic Nephrotic Syndrome, Chronic Lung Disease of Prematurity, Congenital Diseases, Congenital Portosystemic Shunt, Crohn's Disease, Diaphragmatic Hernia, Duchenne Muscular Dystrophy, Hemophilia A, Infant, Extremely Premature, Inflammatory Bowel Diseases

Studies at this site

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) — Recruiting now
• Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset — Recruiting now
• Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia — Recruiting now
• A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome — Running, not enrolling
• A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) — Completed
• International Registry of Congenital Portosystemic Shunt (IRCPSS) — Enrolling by invitation
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A — Completed
• Tracheal Occlusion To Accelerate Lung Growth (TOTAL) Trial for Severe Pulmonary Hypoplasia — Completed